These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18295252)

  • 1. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
    Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
    J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
    Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
    J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell membrane fragments but not intact red blood cells promote calcium oxalate monohydrate crystal growth and aggregation.
    Chutipongtanate S; Thongboonkerd V
    J Urol; 2010 Aug; 184(2):743-9. PubMed ID: 20639050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular cell membranes inhibit growth but promote aggregation of calcium oxalate monohydrate crystals.
    Chutipongtanate S; Thongboonkerd V
    Chem Biol Interact; 2010 Dec; 188(3):421-6. PubMed ID: 20797392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR; Arsenault D; Parks JH; Coe FL; Hoyer JR
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
    Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.
    Atmani F; Khan SR
    BJU Int; 2000 Apr; 85(6):621-5. PubMed ID: 10759652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.